Credevo Pte. Ltd.
LinkedIn logo CEO 
Functionality

Aleksandr Stiblo United States

Global Clinical Trials (GCT) is a premium contract-research organization (CRO) that offers support for the clinical Phase I-IV studies as well as post-marketing activities to Big Pharma, small and medium-sized biotech enterprises, groups and funds, as well as large universities and institutions. Headquartered in Princeton, USA, GCT offers both local and global support through 10 own operational offices in Bulgaria, Czech Republic, Georgia, Hungary, India, Kazakhstan, Latvia, Lithuania, Estonia, Moldova, Poland, Romania, Russia, Slovakia, Ukraine.
GCT team, that now consists of over 100 full-time clinical research professionals, gives individualized attention to each project and provides full range of services following the latest GCP, EMA and FDA guidelines at every stage of product development path. Our monitors and project managers are all certified clinicians experienced in GCP clinical research. Our experience, competent staff, close contact with the KOLs and the immense enrollment potential of the covered region ensure fast study start-up and compliance with the set timelines.
GCT owns 400 sq.m. (4300 ft2) Drug Storage and Distribution facility in St. Petersburg, Russia. It is fully equipped, disaster protected and has multiple modes of storage (ambient, climate controlled, refrigerated, frozen). High standards of work and client satisfaction are proved by the fact that more than 80% of the business come from repeat clients.
Since 2006 GCT is also an Exclusive Partner of “The White Nights” International ophthalmology congress in Russia.
Company Size (Fulltime employees)
Year of foundation
2001
Stock Market and Ticker/Symbol/Number
N/A
Please specify your partnering goal
Networking, new business opportunities
Headquartner in China
Plan in China
GCT is looking for potential new business opportunities, offering full-service clinical trials support worldwide for Chinese pharma companies.
Biotech/Pharma Category
Biotech/Pharma Asset Stage
Medtech Development Stage
Your Service Name
clinical trials, market authorization, registration, consulting
Service Description
logistics, regulatory services, project and site management, pharmacovigilance, medical monitoring, data management, biostatistics, medical writing, GDPR and DPO, EU Legal representation,
Target Client Type
Pharma, Biotech, Device companies
Global Clinical Trials (GCT)
LinkedIn logo Director, Business Development 
Functionality

Muh-Hwan Su

SynCore Biotechnology Co., Ltd ("SynCore" 4192:TT) is a new drug and medical devices development company that integrates innovative technological platforms with current unmet medical needs. SynCore has a comprehensive pipeline in the therapeutic areas of oncology, ophthalmology, dermatology and infectious diseases, with experienced R&D, regulatory, manufacturing and commercialization teams.
Company Size (Fulltime employees)
Year of foundation
2008
Looking for
Headquartner in China
Plan in China
Co-development and out-licensing commercialization rights in China for SB05/EndoTAG-1 for pancreatic cancer therapy, with potential for indication expansion.
SynCore Biotechnology
General Manager 
Functionality

Weiyong Sun Japan

Daiichi Sankyo
Senior Director 

Peilun Sun United States

Located at the High-Tech center, Silicon Valley, ZJ Future was established in 2013 as a bridge between China and the US to offer accelerating services for domestic enterprises with global perspectives. ​



With the vision of accelerating enterprise development and growth, we leverage the complementary advantages of North America, Europe, South America, and the Asia-Pacific regions to connect high-quality projects with industry leaders, promote academic communications and interactions in high-tech fields, aggregate global entrepreneurial and innovative resources, build an effective and efficient global innovation ecosystem, and develop high-level and multi-field cooperation in the fields of economy, trade, investment, science, and technology.
Looking for
Headquartner in China
Biotech/Pharma Category
Service Description
项目投资
ZJ Future
Investment Associate 

Stephen Sunderland China

L.E.K. Consulting is a global management consulting firm that uses deep industry expertise and rigorous analysis to help business leaders achieve practical results with real impact. We are uncompromising in our approach to helping clients consistently make better decisions, deliver improved business performance and create greater shareholder returns. The firm advises and supports global companies that are leaders in their industries — including the largest private and public sector organizations, private equity firms, and emerging entrepreneurial businesses. Founded in 1983, L.E.K. employs more than 1,600 professionals across the Americas, Asia-Pacific and Europe. For more information, visit www.lek.com
Website:
www.lek.com
Company Size (Fulltime employees)
Year of foundation
1983
Funding Status
n/a
Headquartner in China
Plan in China
Established 20+ years in mainland China, serving MNC and China-originated firms with growth strategy services.
L.E.K.
Partner 
Functionality